Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J McCabe

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Carcinogenesis|May 15, 2010
Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesionSebastiano Battaglia, Orla Maguire, James L Thorne, et al.
Endocrinology|February 11, 2014
The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cellsMartin L Read, Robert I Seed, Jim C W Fong, et al.
Molecular Carcinogenesis|November 20, 2014
The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancerMartin L Read, Robert I Seed, Bhavika Modasia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2023
Combined Vorinostat and Chloroquine Inhibit Sodium-Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In VivoMartin L Read, Katie Brookes, Ling Zha, et al.
Human Molecular Genetics|February 27, 2009
Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' diseaseOliver J Brand, Jeffrey C Barrett, Matthew J Simmonds, et al.
Nature|June 11, 2010
Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndromeLouise E Reynolds, Alan R Watson, Marianne Baker, et al.
Human Molecular Genetics|March 6, 2016
Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expressionJoel Smith, Martin L Read, Jon Hoffman, et al.
Ebiomedicine|February 12, 2026
Disulfiram metabolite Cu(DDC)<sub>2</sub> enhances radionuclide uptake in vivo revealing insights into tumoural ablation resistanceKatie Brookes, Jessica S Fear, Caitlin E M Thornton, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Carcinogenesis|May 15, 2010
Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesionSebastiano Battaglia, Orla Maguire, James L Thorne, et al.
Endocrinology|February 11, 2014
The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cellsMartin L Read, Robert I Seed, Jim C W Fong, et al.
Molecular Carcinogenesis|November 20, 2014
The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancerMartin L Read, Robert I Seed, Bhavika Modasia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2023
Combined Vorinostat and Chloroquine Inhibit Sodium-Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In VivoMartin L Read, Katie Brookes, Ling Zha, et al.
Human Molecular Genetics|February 27, 2009
Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' diseaseOliver J Brand, Jeffrey C Barrett, Matthew J Simmonds, et al.
Nature|June 11, 2010
Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndromeLouise E Reynolds, Alan R Watson, Marianne Baker, et al.
Human Molecular Genetics|March 6, 2016
Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expressionJoel Smith, Martin L Read, Jon Hoffman, et al.
Ebiomedicine|February 12, 2026
Disulfiram metabolite Cu(DDC)<sub>2</sub> enhances radionuclide uptake in vivo revealing insights into tumoural ablation resistanceKatie Brookes, Jessica S Fear, Caitlin E M Thornton, et al.
Pageof 5